Viewing Study NCT07161193


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2025-12-29 @ 1:23 PM
Study NCT ID: NCT07161193
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-08
First Post: 2025-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
Sponsor: Hebei Senlang Biotechnology Inc., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module